What's breaking now, across thousands of outlets.
Though Alumis still sees a path forward in lupus, the result made its drug the latest TYK2 blocker to struggle in conditions beyond psoriasis and psoriatic arthritis.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
The Democratic Republic of Congo has recorded more than 6,000 confirmed cases and nearly 3,000 deaths from the country’s worst Ebola epidemic ever, according to the Congolese authorities’ latest toll…
(MedPage Today) -- Clinicians who prescribe isotretinoin for acne or other skin conditions should stop blanket routine laboratory monitoring of liver function and lipids, given overwhelming evidence…
Coming near the start of the fourth day of deliberations, this was the first time the jury gave any indication they were at an impasse.
MasterChef India champion Pankaj Bhadouria has bravely opened up about her ongoing battle with breast cancer. Faced with serious health challenges this August, including painful infections and the…
A Russian research center has announced a new immunotherapy that may eradicate four major cancer types within three to six years.
Cybercriminals breached company data and made an extortion attempt with it, Houston-based Nutex Health said in a filing with federal regulators.
